Source: BioPortfolio

InFlectis BioScience: InFlectis BioScience Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 13082018 Prices from USD $250

SummaryInFlectis BioScience InFlectis is a drug discovery company that identifies and develops small molecule drugs that target the unfolded protein response to treat misfolding protein disorders such as agerelated and neurodegenerative diseases. The compa...

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
1-25
Philippe Guedat's photo - President & CEO of InFlectis

President & CEO

Philippe Guedat

CEO Approval Rating

90/100

Read more